AZD6140 + Placebo to match AZD6140
Phase 1Completed 0 watching 0 views this week๐ค Quiet
33
Development Stage
โ
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Gout
Conditions
Gout, Coronary Artery Disease
Trial Timeline
May 1, 2008 โ Jul 1, 2008
NCT ID
NCT00738842About AZD6140 + Placebo to match AZD6140
AZD6140 + Placebo to match AZD6140 is a phase 1 stage product being developed by AstraZeneca for Gout. The current trial status is completed. This product is registered under clinical trial identifier NCT00738842. Target conditions include Gout, Coronary Artery Disease.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00738842 | Phase 1 | Completed |
Competing Products
20 competing products in Gout